Todd Wallach
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2022First federal award
$7.5MFederal grants as PI8 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
8 awards · $7.5M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 10, 2026 | NIH | SBIR Phase II STING agonist-expressing BCG to enhance bladder cancer therapy | $1.0M | ONCOSTING LLC |
| Jul 22, 2026 | NIH | SBIR Phase II BCG overexpressing a small molecule STING agonist as a vaccine for TB | $987K | ONCOSTING LLC |
| Aug 25, 2025 | NIH | SBIR Phase II BCG overexpressing a small molecule STING agonist as a vaccine for TB | $991K | ONCOSTING LLC |
| Jun 20, 2024 | NIH | SBIR Phase II BCG overexpressing a small molecule STING agonist as a vaccine for TB | $270K | ONCOSTING LLC |
| Aug 28, 2023 | NIH | SBIR Phase II STING agonist-expressing BCG for bladder cancer | $1.1M | ONCOSTING LLC |
| Aug 1, 2022 | NIH | SBIR Phase II STING agonist-expressing BCG for bladder cancer | $2.0M | ONCOSTING LLC |
| Jul 19, 2022 | NIH | SBIR Phase II STING agonist-expressing BCG for bladder cancer | $907K | ONCOSTING LLC |
| May 25, 2022 | NSF | STTR Phase I STTR Phase I: Recombinant BCG as a novel immunoadjuvant for viral infections | $256K | ONCOSTING LLC |
Peer ranks
Federal funding#127
Awards as PI#190
Patents#273
Companies
- ONCOSTING LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.